Reinaldo M. Diaz - 02 Feb 2024 Form 4 Insider Report for Lexeo Therapeutics, Inc. (LXEO)

Role
Director
Signature
/s/ Jenny Robertson, attorney-in-fact
Issuer symbol
LXEO
Transactions as of
02 Feb 2024
Net transactions value
$0
Form type
4
Filing time
06 Feb 2024, 17:58:20 UTC
Previous filing
02 Nov 2023
Next filing
20 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXEO Stock Option (right to buy) Award $0 +36,000 $0.000000 36,000 02 Feb 2024 Common Stock 36,000 $17.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option shall vest and become exercisable on November 2, 2024, and 1/48th of the shares underlying the option shall vest in equal monthly installments thereafter, subject to the Reporting Person's continuous service.